SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · Two top executives at Entrada Therapeutics sold a combined $629K in…

Entrada Therapeutics, Inc. · CLUSTER filed May 4, 2026 at 19:25 ET

At the news

BEARISHIMPACT 5/10

CLUSTER filed May 4, 2026 at 19:25 ET

Two top executives at Entrada Therapeutics sold a combined $629K in open-market sales over a 7-day window, with President & COO Dowden also exercising and immediately selling derivative shares. The total sales represent ~0.11% of market cap, a modest but notable cluster involving both the COO and R&D President, suggesting insider caution ahead of potential catalysts or data readouts.

  • President & COO Nathan Dowden sold 15,000 shares at $15.33 for $230K on May 4, 2026
  • President of R&D Sethuraman Natarajan sold 25,907 shares at $15.39 for $399K on May 4, 2026
  • Dowden also exercised 15,000 derivative shares at $1.74 ($26,100 cost) and immediately sold them
  • Total open-market sales: $629K, representing ~0.11% of $563M market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access